Health and Human Services Secretary Robert Kennedy Jr. navigated intense Congressional questioning in April, confronting lawmakers from both parties on his department's direction. The scrutiny follows a year of internal friction with the Trump administration and legal challenges that have curtailed his "Make America Healthy Again" agenda. Critics say his influence is shrinking, impacting policy shifts for millions of Americans.
During several days of April testimony before Congress, Health and Human Services Secretary Robert Kennedy Jr. faced pointed questions about his alignment with President Donald Trump's executive order to boost domestic glyphosate production. Lawmakers from both sides of the aisle pressed Kennedy on the decision, a policy that directly conflicts with the health-conscious base that initially championed his appointment. This public grilling exposed growing fault lines within the administration’s health strategy.
Senator Brian Schatz, a Democrat representing Hawaii, pressed Kennedy directly on the issue. "This seemed like an opportunity for you to really stand up for your agenda," Schatz stated during the hearing. He articulated the disillusionment felt by many of Kennedy's early supporters. "I've got a lot of friends back in Hawaii who supported you because of issues such as this, and they were hurt, shocked, confused when you were explicitly in favour of Trump's executive order," Schatz continued. "What do you say to those folks?" Kennedy responded by acknowledging his own reservations. "I was very clear with the president about my own displeasure with the executive order," he said. He added that President Trump considered the measure vital for national security.
That explanation highlights a central tension. Kennedy's base, embodied by the "Make America Healthy Again" (MAHA) movement, has long opposed glyphosate, arguing it causes cancer and poses environmental risks. Yet, the Trump administration prioritized agricultural output and economic stability.
The numbers on the shipping manifest tell the real story of agricultural dependence, where domestic production of a widely used herbicide like glyphosate is seen by some as a cornerstone of food security and economic resilience. Trade policy, in this instance, became foreign policy by other means, influencing domestic agricultural supply chains. Kennedy’s tenure, now a year in, has seen him navigate a series of setbacks despite Trump’s initial pledge to let him "go wild" on health initiatives.
Upon taking office, Kennedy moved swiftly to dismantle established public health policies. He fired members of the committee responsible for recommending vaccinations, replacing them with several vaccine skeptics. This new panel then ceased recommending the Hepatitis B vaccine for all newborns.
The Centers for Disease Control and Prevention (CDC) subsequently reduced the number of recommended childhood immunizations. These were significant shifts. Further changes followed.
Kennedy ousted Susan Monarez, then leader of the CDC, after she reportedly refused to approve the new vaccine panel's recommendations. This left the agency without a permanent leader for several months. These policy reversals coincided with a notable public health crisis: the United States experienced its worst measles outbreak in decades, with more than 4,000 cases reported across 2025 and 2026.
The disease claimed the lives of two children in Texas. For some in Kennedy's MAHA base, these early vaccine policy changes represented a victory. Jacqueline Capriotti, who worked on social media for Kennedy's campaign and manages a Facebook group for MAHA mothers, voiced support for the shift. "It just gives people a little more choice or time to make those decisions on their own," Capriotti said.
She sees it as fostering a "healthy conversation" about "informed consent" and understanding what goes into one's body. This perspective resonates with a segment of voters seeking greater individual autonomy in health decisions. However, these early policy wins quickly faced resistance from external forces and even the White House.
In March, a judge halted much of Kennedy's vaccine policies. The ruling cited a lack of appropriate credentials among the newly appointed members of the vaccine panel. HHS indicated it would appeal the decision, but has not yet done so.
This legal intervention effectively paused a core part of Kennedy’s initial agenda. Simultaneously, the Trump administration directed Kennedy to shift away from vaccine politics before the upcoming midterm elections, Kennedy allies confirmed to the BBC. Whit Ayres, a longtime Republican pollster, suggested the Trump team concluded that promoting vaccine skepticism was "political poison." Ayres explained that the overwhelming majority of Americans support vaccines.
This strategic shift reflects a calculation of political capital and public opinion. Abby McCloskey, an advisor to Republican campaigns, characterized the March judicial ruling as something of a benefit. "It almost takes it off of RFK Jr's plate and gives him reason to not talk about it," McCloskey noted. This external intervention provided a convenient exit from a politically sensitive topic.
The pivot from vaccine advocacy became evident during Kennedy's April appearances before Congress, where he publicly stated that every child should be vaccinated against measles. This statement marked a notable departure from his earlier stance. With his vaccine campaign stalled, Kennedy has redirected his focus to other issues central to his MAHA base.
These include chronic disease, food quality, and environmental safety. He has overseen a revision of the American food pyramid, a move that received a mixed reception from public health experts. He has also attempted to persuade corporations to voluntarily eliminate synthetic food dyes.
These initiatives align more closely with the broader wellness and nutrition goals of his supporters. Yet, even these efforts have encountered friction with President Trump's preferences and policies. Trump, known for his appreciation of fast food, had previously signed the glyphosate order that angered many MAHA supporters.
Kennedy, despite his personal misgivings, ultimately released a public statement supporting Trump's order, citing the agricultural sector's reliance on the herbicide. "I don't think he had a choice," said Jeff Hutt, a former national field director for the MAHA Institute. Hutt added, "I wish he had not done it. I think that's the way that most people felt." This illustrates the constraints on Kennedy's independent action.
Zen Honeycutt, founder of Moms Across America, an advocacy group aligned with MAHA, described many like-minded mothers as "outraged" by the glyphosate decision. Honeycutt suggested the executive order seemed to have been influenced directly by chemical companies. "It's seemed to us like the chemical companies were sitting there, that they wrote [the order] for them," she said. Despite these frustrations, Honeycutt affirmed her trust in Kennedy’s core mission. "But I do not doubt his commitment to the health and safety of our children," she stated.
This reflects a nuanced loyalty among his supporters, distinguishing the man from the policy outcomes. An HHS official told the BBC that the economic security implications of the agricultural sector losing access to necessary pesticides would be "severe." The official added that the agency's revised dietary guidelines now emphasize whole fruits and vegetables, aiming to lessen dependence on "chemical-intensive" agricultural production. This indicates a departmental effort to balance agricultural needs with health goals, even if the glyphosate decision remains contentious.
A Politico poll suggests that 47% of voters who identify as MAHA believe Trump and Kennedy have not done enough, compared to 44% who say they have. This shows a divided opinion within his core constituency. Despite the internal conflicts and policy reversals, President Trump appears to value Kennedy's ability to communicate with a specific segment of the electorate.
Republican strategists suggest Trump sees Kennedy as a powerful messenger. In the autumn, the health secretary is scheduled to travel to several swing states as a political surrogate, campaigning ahead of the November midterm elections, Politico reported. This suggests a continued utility for Kennedy, even if his policy autonomy is limited.
Kennedy is also expanding his public outreach through other channels. He is launching his own podcast, designed to feature "fearless conversations with critical thinkers, including independent doctors." This platform could allow him to address issues directly, bypassing some administrative constraints. Additionally, he has announced a new initiative to research the effects of microplastics, and a renewed focus on tackling chronic disease.
These areas represent a pivot towards broader public health concerns that may prove less politically charged than vaccine policy. It remains unclear whether this new strategic direction will persuade Americans to fully embrace the MAHA agenda and its alignment with Trump. Whit Ayres believes Kennedy faces an uphill battle. "Kennedy is so widely associated with anti-vaccine advocacy that it's going to be difficult for him to redefine himself in any other way," Ayres explained.
Abby McCloskey argued that Kennedy's public messaging efforts alone are insufficient. The Trump administration, she said, has missed an opportunity to connect with "a large constituency" of MAHA parent voters who prioritize nutrition and children's health issues. McCloskey called for concrete policy proposals. "What's really missing is what the next suite of concrete policy items or agenda items are like," she noted.
Jeff Hutt acknowledged the challenges but maintained that Kennedy could still count on his base. "People who supported Bobby [Kennedy] understand that his ability to be a change agent is really limited by how much rope the president gives him," Hutt said. However, Hutt also suggested that Kennedy and his team might underestimate their own political power. "They don't understand how strong they could be politically," he concluded. The coming months will reveal if Kennedy can effectively redefine his public image and translate his renewed focus into tangible policy achievements, or if his role will remain primarily that of a spokesperson ahead of the critical midterm contests.
Key Takeaways
— - Health Secretary Robert Kennedy Jr. faces significant internal friction with the Trump administration and external legal challenges.
— - A court ruling in March halted Kennedy's vaccine policy changes, citing a lack of credentials among his appointed panel members.
— - The White House has directed Kennedy to pivot away from vaccine politics, viewing it as a political liability ahead of midterm elections.
— - Kennedy is now focusing on chronic disease, microplastics, and food quality, while preparing to campaign for Trump in swing states.
Source: BBC News
